Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Right?!? Love that last kick to the crotch before the announcement.....I asked about that partnership months ago? Dilute and reverse split before we announce.... Kma!
don't hold your breath - how many times have we been here?
agree - it was a direct offering though so technically the market didn't have to soak up the new shares. And it's still within the original 50 million OS - I'm just trying to make myself feel better. I don't believe it should have cratered like this but again, trying to make myself feel better.
what's all this about today?
This little buy rating is giving this a little kick. If management was smart they would cancel their f*ing meeting and release some positive data on their drugs, at minimum an update on the Chinese partnership. But that's asking a lot from these folks, I'm sure they will issue some shares to kill any momentum.
Management devastated this stock. They had momentum in the right direction and just kicked it in the nards, multiple times. This will need some serious good news from the Chinese, if that partnership is even real.
Painful - like watching liberals self implode with TDS.
IEXG - 121,600 share offering just showed up again and disappeared. Same trade as a few days back before the drop - sure looks like signals to me.....
looks like I'm always the last one to know when to sell.....I wish I was in the big club. Did I miss something?
Big ask at 2.26 for 121,600 - not sure what that means, either someone wants to dump a large chunk or giving a signal for someone to cover a large short position.
Update: The exchange listing the order was IEXG, seems to have come off now.....
Presentation this weekend correct?
I get the feeling RNN will run today, the volume dried up on this small pullback. But today's behavior strikes me like it will creep up and then run.
Agreed on the .22. I had not read that peer review before. Found that fairly informative on the Chinese partnership. I have no idea what China's regulations are like but I'm sure it's not like the US. 30% of proceeds would be very nice -
I wonder if this article is fueling the moves. I don't have an account or willing to create one.
https://www.bizjournals.com/baltimore/news/2018/05/15/md-biotech-firm-nears-market-with-two-cancer-drugs.html
That's how you finish the day and week....very nice
moving again on no news -
it's moving now - some big bids pushing it up. I'm gitty at .22 - almost to my break even point....almost.
covering before earnings? We all know earnings will be bad....unless we don't know something that's out there. I'm still curious about the Chinese partnership and the royalty payments. Let's hope those tests are going really well -
well that ended badly - wth.....
Today is a good follow through to yesterdays move. Solid move up without the explosive moves which never last - RNN has been at some of the lowest levels for so long it was only a matter of time before it moved up. It will be interesting how the second half of the day goes. More moves up or trickle back down?
Maybe news has leaked, maybe the testing in China is going really well and the expectation of a royalty payment?
This move needs follow up news or another good leg up or we drift right back.
That's what I can't understand, all time lows - that means EVERYONE would be selling at a loss.
It's a 10k of jibber jabber, but there was some info i hadn't seen in their agreement with Haichang. Didn't we read this trial will have initial results this year? That would be a good indicator if Haichang would potentially exercise their exclusive license. So unless the U.S. Goes to war with China, we may get some funding next year......
Haichang will fund all development activities through completion of the Phase 2a clinical trial up to an aggregate amount of $10,000,000 and the parties will share downstream licensing fees and royalties paid by third parties in an agreed ratio in connection with the further development and commercialization of RX-0201 for the treatment of HCC. If Haichang exercises its right of first negotiation after completion of the Phase 2a clinical trial to obtain an exclusive license to further develop and commercialize RX-0201 in China, Haichang will pay customary license fees, milestone payments and royalties to Rexahn. Any clinical trials conducted by Haichang will be designed to meet both FDA and China Food and Drug Administration requirements.
I've watched this stock for awhile now, read a lot of posts by many folks here. I hope this stock works out in the long run. If acgx isnt legit, they sure go to great lengths to pull it off.
Spent some time on their site and it sure reads legit. Filings look in order, statements are clean, cover their growth strategy/transformation...etc Sounded compelling. I Dont like this packaging company being touted as a "huge" partner, their company site is garbage, looks fake. That said, its packaging material for fruit....Not exactly a glam buisness, but dang that site is bad. Maybe acgx/peoplevine solution can help take "egg cartons" higher....in turn provide shipping for the region. Details would be nice....
I would like to get into their financials a bit more. Like what's their cogs? profit margins are terrible. Been dealing with some debt too so that plays into this. OS are pretty heavy but OTCs are notoriously bad, my quick calc share value would be about .012/share.
I don't know, seems legit but I'm sceptical, but willing to toss a little at it, I mean it's .0024. So I'm not out much.....throw my Trump tax cuts at it!! I'm not tired of winning yet, roll this.
We were sitting at all time lows, I've been in this clam for 7 years. Makes me sad when I think about it.....regardless, who would be selling at those prices?
Heavy volume at the end of the day and the price didn't move. Has the smell of manipulation but who knows, surely not us.
I'm a patient person but this is ridiculous, .16 seriously...
I don't know if the MM's are stalling movement on this or retail simply does not like this stock. I don't understand the lack of volume given the news. It's possible the absence of details regarding the "partnership" has people waiting. Mentions of royalties and milestone payments but no details. Let's go RNN PR department.....
RNN hasn't updated their pipeline on their own website. I like the products, marketing needs some help.
Data always looks good but here we are $.24 - good to see some volume and a little price movement. Need a partnership.....nothing else will move this significantly. I can't see MM's letting this go without big pharma in RNN's pockets.
The silent majority wait quietly
Did I miss something or is this another plunge attempt? I may have to roll some more funds into this. Promised myself I wouldn’t and let my initial investment ride but these prices at too tempting. .17/share for those of us who have been here pre split.
That and I'm hopeful of the institutional buyers vs. indirect. That would lead to believe these institutions think it's worth an investment. 7 years and waiting -
It's as if they don't want the share price to increase at all.
Seaport Global sets a price target of $13, $1.30 for those of us that have been here for a bit. It's much easier to get drugs approved for the EU then US. RNN needs a good partner soon -
There's going to be a whole lot less shares out there very soon. See you all on the flip side -
I didn't see that coming and I don't believe it warranted the plunge. I'm not selling, forget the raiders, you can't have my shares. nothing has changed....RNN still has four catalysts for the year.
Looks like management rewarded themselves with more shares. I'm really impressed with the strength of the stock today. It had all the push and shove to go down but scraped and clawed back.
I wouldn't mind trending in the .60s for a few days before the next leg up.
Old traders getting out, new traders coming in. Small consolidations on its way much higher, four major data points to be released Q2/Q3. I've been here way too long to get out now